Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperdal Consta for Symptomatic Remission in Schizophrenia
NCT00216528Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jul 2005
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of risperidone in schizophrenia, schizoaffective disorder, sponsored by Janssen Pharmaceutical. Started Jul 2005; status: completed.
02
Drugs
risperidone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00216528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216528.